We are developing next-generation rapid and accurate diagnostics to quickly identify superbugs so we can give the right drug to patients the first time. This is important to better treat disease and reduce unnecessary antibiotic use.

Project members

Key contact

Dr Mark Blaskovich

Director, IMB Centre for Superbug Solutions
Principal Research Fellow - GL
Institute for Molecular Bioscience